The tamoxifen derivative ridaifen-B is a high affinity selective CB 2 receptor inverse agonist exhibiting anti-inflammatory and anti-osteoclastogenic effects
Lirit N. Franks, Benjamin M. Ford, Toshifumi Fujiwara, Haibo Zhao, Paul L. Prather
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'The tamoxifen derivative ridaifen-B is a high affinity selective CB 2 receptor inverse agonist exhibiting anti-inflammatory and anti-osteoclastogenic effects'. Together they form a unique fingerprint.